NEWS
Genome Region Tied to Risk of Second Cancers after Radiation Therapy
A new study may provide an important clue about the long-term risk of second primary cancers in children with Hodgkin lymphoma who receive radiation therapy as part of their treatment.
In the study, researchers identified two genetic variants, called single nucleotide polymorphisms (SNPs), in a region of chromosome 6 that were strongly associated with an increased risk of a second cancer in this group of cancer survivors. Read more > >
Mobile Phone Use Does Not Raise Cancer Risk in Children and Adolescents
Case-control study investigated mobile phone use among children and adolescents with brain tumorsComputer System for Reading Mammograms Does Not Appear to Improve Cancer Detection
Updated study results suggest that the costs may outweigh the benefitsHigher Breast Density Linked to Increased Cancer Risk and Aggressive Tumors
Breast density is a risk factor for a range of breast cancer subtypes in postmenopausal womenGenetic Study Provides Clues to Non-Hodgkin Lymphoma
Researchers find frequent mutations in genes involved in packaging DNAStudies Reveal the Genetic Complexity of Head and Neck Squamous Cell Cancers
Mutated genes include Notch1 and others that regulate cell differentiationAlso in the Journals: Key Genetic Mutations Found in One Type of Brain Cancer
A MESSAGE TO READERS
NCI Cancer Bulletin Publication Break
The NCI Cancer Bulletin will not be published on August 23. Our next issue will be released on September 6, when we resume our usual biweekly publication schedule. If you are not yet a subscriber, please submit your e-mail address in the toolbox at the top right-hand corner to begin your free subscription.
.
IN DEPTH
Tracking the Rise of Robotic Surgery for Prostate Cancer
For many, the robotic procedure has become the surgical option of choice
New Guidance for Personalized Breast Cancer Screening
Breast density is a strong indicator of who might benefit from earlier mammograms
Featured Clinical Trial: Comparing Targeted Lung Cancer Therapies Based on KRAS Mutation Status
Will targeted drugs work better separately or together for advanced lung cancer?
Translational Science: From Molecular Information to Cancer Medicine
Attendees explored how molecular information may lead to more effective cancer detection and treatment
UPDATES
Cancer.gov Update
- Updated HINTS Website Unveiled
Notes
- Varmus Reflects on First Year as NCI Director
- DCEG's Chatterjee Wins Statistical Awards
- NCI Researchers Win NIH Director's Awards
- CCR's Gonzalez and Colleagues Honored for Diagnostic Test
- Comments Sought on Changes to Human Subject Protections
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
